ArticleJCPP advances2026
Maternal influenza vaccination during pregnancy and risk of autism spectrum disorder in the offspring.
Article in JCPP advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Vaccination has been proposed as a potential risk factor for autism spectrum disorder (ASD), contributing to public hesitancy and mistrust toward immunization. Influenza vaccination during pregnancy is considered safe and effective in preventing serious maternal complications and adverse birth outcomes associated with influenza infection. However, limited research exists regarding the long-term impact of maternal influenza vaccination on offspring neurodevelopment. Methods: We conducted a retrospective cohort study of all singleton-live births among members of Clalit Health Services (CHS), Israel's largest healthcare provider, between January 2016 and December 2020, with follow-up through May 2024. Offspring with developmental disorders of known genetic etiology were excluded. Maternal influenza vaccination during pregnancy (exposure) and offspring ASD diagnosis (outcome) were identified via CHS electronic medical records. The association between exposure and outcome was assessed using Cox proportional hazards models, adjusting for sociodemographic, maternal, and gestational covariates. Results: Of 153,321 children included in the analysis, 39,361 (25.7%) were exposed to maternal influenza vaccination during pregnancy. The cumulative incidence of ASD was 3.6% for offspring of vaccinated mothers and 2.9% for offspring of unvaccinated mothers resulting in a modestly increased hazard ratio (HR) of ASD associated with influenza vaccination during pregnancy (HR = 1.22, 95% CI: 1.14-1.31). However, this association was no longer evident after adjustment for sociodemographic and clinical covariates (aHR = 0.97, 95% CI: 0.91-1.05). Conclusion: Maternal influenza vaccination during pregnancy was not associated with an increased risk of ASD in offspring. These results provide valuable confirmation of similar findings from earlier studies, thus further support the long-term safety of maternal influenza vaccination as a preventive healthcare measure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.